Endocrinology Flashcards
Next step in management for pituitary mass/incidentolomas
Check functionality (Prolactin, TSH/T4, IGF1, 1mg DMS test)
Clinical features of prolactinoma/hyperprolactinemia
Management
F: galactorrhea, amenorrhea
M: impotence, decreased libido
Dopamine agonist
(Bromocriptine, carbegoline)
Surveillance for prolactinoma
> 1cm: MRI q6mo + visual field testing
< 1cm: MRI q1year
DM drug of choice in kidney disease
Meglitinides
DM Med to avoid in obese
Sulfonylureas (ie glyburide)
DM drug of choice in obese
Metformin
DM Med to avoid in kidney disease
Metformin
Acarbose
DM Med to avoid in CHF
Thiazolidinediones (ie pialitazone)
Side effects of GLP-1 agonist (ie liraglutide) and DPP-4 inhibitors (ie sitagliptin)
Pancreatitis
Side effect if SGLT2 inhibitors (ie empagliflozin)
UTI
Euglycemic Ketoacidosis
Fourniers gangrene
False elevation of HbA1c
Decreased RBC turnover Anemia (iron, B12, folate def) ESRD Asplenia Hemiglobinopathies Sickle cell trait
Falsely lower HbA1c
Increased RBC turnover Hemolytic anemia HIV Blood transfusions Iron, B12, folate def treatment EPO
Most common bacteria in diabetic foot ulcer
Staph aureus
Elevated proinsulin
Elevated c-peptide
Elevated insulin
Sulfonylurea use
No proinsulin
No c-peptide
Elevated insulin
Insulin use
Very Elevated proinsulin
Elevated c-peptide
Elevated insulin
Insulinoma
RAIU with diffuse uptake
Grave’s disease
TSH adenoma
RAIU with areas of increased uptake surrounding by areas of decreased uptake
Multinodular goiter
RAIU with areas of increased focal uptake surrounded by area of decreased uptake
Toxic nodule
RAIU with < 5% uptake
Thyroiditis
Next step in management for hypopituitary hypothyoidism
ACTH stim test
r/o adrenal insufficiency
Treatment for thyroid stone
Beta blockers
Then steroids
TrAb (thyroid receptor Ab)
Graves
Treatment for myxedema coma
Steroid + T4 + T3 + Abx
Management of levothyroxine during pregnancy
Increase dose by 50%
Thyroid nodule
High TSH
Cold
FNA
Thyroid nodule
Low TSH
Hot
RAIU
Elevated Ca
Elevated PTH
UrCa > 200g/day
Primary hyperparathyroidism
Elevated Ca
Normal PTH
UrCa < 100mg/day
Familial hypocalciuric hypercalcemia
Elevated Ca
Low PTH
Malignancy
Vit D toxicity
Sarcoidosis
Indications for parathyroid surgery
Elevated PTH Age < 50 or elevated risk of complications OR sCa > 1mg above normal OR UrCa > 40mg/day OR CrCl < 60 OR symptomatic
Low PTH
High Ca
High Phos
Vit D toxicity (25 OH D3)
Sarcoidosis (1, 25 OH2 D3)
Low PTH
High Ca
Low Phos
Malignancy
Milk alkali
Low PTH
low Ca
High Phos
Hypoparathyroidism
Low PTH
low Ca
High Phos
Low K
HypoMg
High PTH
Normal/low Ca
Normal/low Phos
High ALP
Vit D deficiency
High PTH
low Ca
High Phos
Short 4th and 5th metacarpals
Pseudohypioarathyroidism
Normal PTH
Normal Ca
Normal Phos
Short 4th and 5th metacarpals
Pseudopseudohypoparathyoridism
Drugs that cause osteoporosis
Steroids
Aromatase inhibitor
PPI
Biggest risk factor for osteoporosis
Sedentary lifestyle
Thickening and sclerosis of bone
Increased ALP
Normal Ca, Phos, PTH
Paget’s disease of bone
Normal BP
17(OH) progesterone elevated
21 B hydroxylase deficiency
Non-classical CAH
HTN
Low L
Elevated Aldosterone
Low renin
Primary aldosteronism
Low BP
High K
Low Aldo
low renin
Hyporeninemic hypoaldosteronism
Next step in management after aldo:renin > 20:1
Bilateral adrenal vein sampling
Best test to confirm hyporeninemic hypoaldosteronism
ACTH stim test
Cushing work up
24 hr free ruin cortisol (>100mcg/day confirms Cushing’s)
Late night salivary cortisol
1mg DMS suppression test
Elevated cortisol
Elevated DHEA
Elevated ACTH
Cushing’s disease
Elevated cortisol
Low DHEA
Low ACTH
Adrenal adenoma (zona fasciculata)
Elevated cortisol
Very Elevated DHEA
Low ACTH
Adrenal cancer (zona reticularis)
Low cortisol
Low DHEA
Low ACTH
Exogenous steroids
Next steps in management If initial Cushing w/u positive
Serum ACTH level If + 8mg DMS test If ACTH suppressed, MRI brain If MRI neg, bilateral inferior petrosal sinus sampling If < 2-5x peripheral ACTH, CT chest
Confirmation of Addison’s disease
AM cortical < 3mg
If AM cortisol 3-15mg, do ACTH stim
If cortisol < 18mcg (primary)
If cortisol > 18mcg (secondary)
Management for primary Addison’s
Management for secondary Addison’s
Hydrocortisone + fludrocortison
Hydrocortisone only
Screening for pheochromocytoma
24 hr Ur fractionated metanephrine and catecholamines
Initial management for adrenal incidentaloma
Check functionality 1mg DMS suppression test 24 hr Ur metaneph/catechol Aldo/renin. K 17(OH) ketosteroids
Surgical indication for adrenal incidentalomas
> 4cm regardless of function
< 4cm + functioning
Size increase by 1 cm per yesr
Adrenal incidentaloma
< 10 HFU
> 10 HFU
Fat
Cancer or Pheo
Low BP
Hemianopsia or nerve palsy
Pituitary lesions or dense lesion in sella
Pituitary apoplexy
Dense suprasellar calcification
Craniopharyngioma
Small testes
Gynecomastia
High FSH and LH
Klinefelter (47 XXY)
High risk for breast cancer
GnRH def.
Anosmia
Kallman
PSA > 2x
Prostate biopsy
Testosterone level low in obese or elderly
Check free testosterone
Primary amenorrhea
Web neck
Short statue
Turner syndrome (45XO)
Primary amenorrhea
No vagina or uterus
Ovaries and breast okay
Mullerian syndrome (46XY)
Mayer Rokitansky Kuster Hauser Syndrome
Primary amenorrhea Acne Clitoromegaly Hirsutism No ovaries or breasts
46XY. Gonadal dysgensis
Primary amenorrhea
Strophic vagina
No cervix, Pubic or axillary hair
Breasts
Androgen insensitivity syndrome (46XY)
Evaluation of secondary amenorrhea
1) pregnancy test
2) pituitary hormones
3) progesterone trials. If bleed, PCOS
4) estrogen/progesterone trial. If bleed, primary ovarian failure. If no bleed, primary uterine failure